Analytical Data
-
Gene name
Spock2
- Application
-
Alternative Names
SPARC/osteonectin, CWCV, and Kazal-like domains proteoglycan 2
-
Species
Mouse
-
Source
E. coli
-
Tag
N- His & C- Myc
-
Purity
Greater than 90% as determined by SDS-PAGE.
-
Uniprot
Q9ER58
-
Expression Region
23-423aa
-
Molecular Weight
52.1 kDa
-
Endotoxin
< 1.0 EU per μg protein as determined by the LAL method.
-
Form
Freeze-dried powder
-
Buffer formulation
PBS, pH7.4, containing 0.01% SKL, 1mM DTT, 5% Trehalose and Proclin300.
-
Reconstitution
Reconstitute in ddH2O to a concentration of 0.1-0.5 mg/mL. Do not vortex.
- Customization
-
Stability Test
The thermal stability is described by the loss rate. The loss rate was determined by accelerated thermal degradation test, that is, incubate the protein at 37℃ for 48h, and no obvious degradation and precipitation were observed. The loss rate isless than 8% within the expiration date under appropriate storage condition.
-
Storage & Shelf Life
Samples are stable for up to twelve months from date of receipt at -20℃ to -80℃. Store it under sterile conditions at -20℃ to -80℃. It is recommended that the protein be aliquoted for optimal storage. Avoid repeated freeze-thaw cycles.
-
Shipping
In general, recombinant proteins are supplied as lyophilized powder and shipped at ambient temperature. For bulk packages, the proteins are provided as frozen liquid and shipped with blue ice, unless otherwise requested by the customer.
Quality inspection process
Related Products
Protein Description
Spock2, a member of the SPARC (Secreted Protein Acidic and Rich in Cysteine) family, plays a crucial role in various biological processes, including cell adhesion, tissue remodeling, and tumor progression. Research on Spock2 has gained momentum due to its potential implications in cancer biology, particularly in how it influences the tumor microenvironment and metastasis. Elevated levels of Spock2 have been associated with poorer prognosis in several cancer types, highlighting its role as a potential biomarker and therapeutic target. Given its involvement in modulating extracellular matrix interactions and cell signaling pathways, the recombinant expression of Spock2 protein is of significant interest for further functional studies. Understanding the structure and function of Spock2 can facilitate the development of novel cancer treatments and improve our understanding of tumor biology. Through recombinant protein techniques, researchers can produce Spock2 in host systems, allowing for detailed investigations into its biochemical properties, interactions, and regulatory mechanisms in cellular contexts. Thus, the study of Spock2 recombinant proteins is critical for elucidating its role in health and disease, with the potential for translational applications in cancer therapy.
